Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2006
06/01/2006WO2006056245A1 Use of a human chitinase-like protein in diagnosis and therapy
06/01/2006WO2006056080A1 Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
06/01/2006WO2006056037A1 Method of detecting kidney dysfunction
06/01/2006WO2006056001A1 Device for qualitatively and quantitatively analyzing analytes
06/01/2006WO2006055993A1 Separating device, in particular for bodily fluids, and receptacle equipped with this separating device
06/01/2006WO2006042555A3 Lysing reagent for simultaneous enumeration of different types of blood cells in a blood sample
06/01/2006WO2006021807A3 Methods of diagnosis of attention deficit hyperactivity disorder (adhd)
06/01/2006WO2006021648A3 Multidisciplinary automatic analyser for in vitro diagnosis
06/01/2006WO2006017174A3 Antibodies against cancer produced using masked cancer cells as immunogen
06/01/2006WO2006014723A3 Predicting alzheimer's disease
06/01/2006WO2006014706A3 Methotrexate derivatives useful for treating cancer and arthritis
06/01/2006WO2006007134A3 Jm-27 asa a marker of benign prostatic hyperplasia
06/01/2006WO2006005975A3 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof
06/01/2006WO2006005825A3 Novel polypeptides for isolating in vitro and preventing staphyloccocal infections on joint prostheses and other implanted foreign materials
06/01/2006WO2005124647A3 Isolation and purification of biochemicals
06/01/2006WO2005123779A3 Antibodies binding to cd34+/cd36+ fetal but not to adult cells
06/01/2006WO2005121801A3 Diagnosis of anemia and optimizing treatment for organ repair
06/01/2006WO2005119259A9 Population based prediction methods for immune response determinations and methods for verifying immunological response data
06/01/2006WO2005118870A3 Nanoscale electronic detection system and methods for their manufacture
06/01/2006WO2005116239A3 Diagnostic assays for neurodegenerative diseases
06/01/2006WO2005114220A3 Compositions, kits, and methods for calibration in mass spectrometry
06/01/2006WO2005114203A3 Dominant b cell epitopes and methods of making and using thereof
06/01/2006WO2005108989A3 Assay for antibodies
06/01/2006WO2005106494A3 Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination
06/01/2006WO2005103692A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
06/01/2006WO2005094356A3 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
06/01/2006WO2005089206A3 Modulators of ion channel trpa1
06/01/2006WO2005086630A3 Reduced complexity transmission line and waveguide fault tester
06/01/2006WO2005084278A3 Methods for identifying or screening for agents that modulate 17beta- hsd3
06/01/2006WO2005069883A3 Method and apparatus for transmission line and waveguide testing
06/01/2006WO2005048936A3 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof
06/01/2006WO2005041757A3 Detection of neuropeptides associated with pelvic pain disorders and uses thereof
06/01/2006WO2005019794A3 Method for deconvolution of impedance spectra
06/01/2006WO2005017123A3 Mptens as modifiers of the pten pathway and methods of use
06/01/2006WO2004093644A3 Methods and apparatus for genetic evaluation
06/01/2006WO2003087310A3 Directed protein docking algorithm
06/01/2006WO2003025542A3 Immune response associated proteins
06/01/2006US20060117396 Assay methods for identifying modulators of OPSDL3 and transgenic knockouts
06/01/2006US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor
06/01/2006US20060116505 Glucose and/or fructose transporter naglt1 and its gene
06/01/2006US20060116504 polypeptides used as biomarkers for the analysis and medical prognosis of liver disorders associated with alcoholism
06/01/2006US20060116317 Dyeing keratin material; using ninhydrin material
06/01/2006US20060116315 Method of screening agent for improving memory and learning ability
06/01/2006US20060115908 Multiplexed analyses of contaminant-laden gas in a particle impact collector
06/01/2006US20060115907 Immune complex-specific antibodies for increased sensitivity in immunoassay array tests
06/01/2006US20060115906 Sensor surface comprising an improved signal-noise ratio
06/01/2006US20060115905 Microscale diffusion immunoassay in hydrogels
06/01/2006US20060115903 Relevance of achieved levels of markers of systemic inflammation following treatment
06/01/2006US20060115897 Compositions and methods modulating variola and vaccinia virus
06/01/2006US20060115896 Diagnostic test for west nile virus
06/01/2006US20060115875 Characterizing hepatitis C viral infection by determining a similarity between a viral sequence of an hypervariable region 1 (HVR1) of the second envelope protein (E2) region of an hepatitis C virus that infected the host and a variable region kappa light chain of an immunoglobulin of the host
06/01/2006US20060115874 Enrichment method for variant proteins with altered binding properties
06/01/2006US20060115869 Uses of carbamoyl phosphate synthetas for the diagnosis of inflammatory diseases and sepsis
06/01/2006US20060115868 Activation mixture
06/01/2006US20060115867 TRIM 5 related protein as a biomarker of neurodegenerative disease
06/01/2006US20060115866 Permits accurate assay of a target substance in a specimen by the use of two types of characteristic antibodies
06/01/2006US20060115865 Lamotrigine analogs
06/01/2006US20060115864 Identifying modulators of ubiquitin-mediated proteolysis; treatment and prevention of cell proliferative, arthritic and respiratory system disorders
06/01/2006US20060115863 Inositol phosphate detection assays
06/01/2006US20060115862 Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
06/01/2006US20060115861 For controlled release of a drug; porous silicon oxide body with at least some of the pores capped with gold particles, which are connected to the body with a polypeptide that includes a variable region of an antibody having a specific amino acid sequence
06/01/2006US20060115860 Immunologic assay for detection of autoantibodies to folate binding protein
06/01/2006US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof
06/01/2006US20060115858 Trace amine 1 receptor of the African green monkey
06/01/2006US20060115857 for sensing the presence of an analyte component without relying on redox mediators; conductive polymer/double-stranded DNA strands aligned in uniaxial orientation with plurality of molecular recognition headgroups having an affinity for the analyte component and being attached to the ends of the strands
06/01/2006US20060115856 2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease
06/01/2006US20060115855 FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
06/01/2006US20060115854 Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
06/01/2006US20060115849 Screening methods
06/01/2006US20060115847 immunological TB diagnostic tool based on a combination of epitopes from proteins encoded by regions of the M. tuberculosis genome that are not present in the BCG vaccine strain or in the most common non-tuberculosis mycobacteria
06/01/2006US20060115841 Method and system for elucidating the primary structure of biopolymers
06/01/2006US20060115839 Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
06/01/2006US20060115834 Methods of identifying metastatic potential in cancer
06/01/2006US20060115832 Detection of cancer cells in body fluids
06/01/2006US20060115831 Map
06/01/2006US20060115823 For detecting entero-hemorrhagic Escherichia coli in clinical examinations, public health examinations, food evaluations and food poisoning examinations; oligonucleotides preferable for composing a rapid and specific gene testing reagent
06/01/2006US20060115817 Span-xb gene and protein for the diagnosis and treatment of cancer
06/01/2006US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds
06/01/2006US20060115814 Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens
06/01/2006US20060115813 Intracellular signaling molecules
06/01/2006US20060115812 Detecting hyperplasia or adenocarcinoma of the endometrium; measuring and comparing levels of stress-induced phosphoprotein-1
06/01/2006US20060115810 Microarrays of functional biomolecules, and uses therefor
06/01/2006US20060115809 Microarrays of functional biomolecules, and uses therefor
06/01/2006US20060115808 Microarrays of functional biomolecules, and uses therefor
06/01/2006US20060115806 Global analysis of transposable elements as molecular markers of cancer
06/01/2006US20060115559 Apparatus and method of contaminant detection for food industry
06/01/2006US20060115488 Identification of new CD8 epitopes from HIV-1 proteins with therapeutical and vaccinal properties against HIV infections
06/01/2006US20060115482 Modifications of histone proteins as indicators of cell proliferation and differentiation
06/01/2006US20060115477 Neuropilin-1 inhibitors
06/01/2006US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders
06/01/2006US20060115379 Magnetostrictive pump
06/01/2006US20060115146 Pathological diagnosis support device, program, method, and system
06/01/2006US20060114456 Automated laser capture microdissection
06/01/2006US20060114115 Solid state sensor for carbon monoxide
06/01/2006US20060113187 Biosensors comprising semiconducting electrodes or ruthenium containing mediators and method of using the same
06/01/2006US20060113163 Pulling device for container inspection system
06/01/2006DE19653685B4 In vitro Zellsystem vaskulärer glatter Muskulatur für pharmakologische und physiologische Untersuchungen In vitro cell system vascular smooth muscle for pharmacological and physiological studies
06/01/2006DE10251721B4 Verfahren zur Beschickung von Probenkammern mit Suspensionsproben A method for loading of sample chambers with suspension samples
06/01/2006DE10244502B4 Molekulargewichtsmarker für Proteine und Verfahren zu dessen Herstellung Molecular weight markers for proteins and methods for its preparation
06/01/2006DE10239530B4 Kapillarrheometer Capillary